% Expired Patents = 100.0

Forward Citations = 86

Loading Chart...

1 inventor (with patents filed for the assignee):

Alan Bruce Montgomery (10 out of 27 patents)

10 patents: Sort by Forward Citations

1. 9526698 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2016-12-27),

2. 9526697 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2016-12-27),

3. 9526696 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2016-12-27),

4. 9526695 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2016-12-27),

5. 9486462 - Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties (2016-11-08),

6. 8826904 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2014-09-09),

7. 8820323 - Methods to administer formulations of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2014-09-02),

8. 8636984 - Aerosol formulation of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2014-01-28),

9. 8636983 - Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2014-01-28),

10. 8603439 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis (2013-12-10),

Company Overview

Cardeas Pharma Corporation, based in Seattle, WA, specializes in the development of innovative therapeutics aimed at addressing unmet medical needs. The company focuses on advancing treatments in the field of neurology, with a commitment to improving patient outcomes through cutting-edge research and technology. By leveraging a deep understanding of disease mechanisms, Cardeas Pharma aims to deliver transformative solutions that enhance the quality of life for patients and their families.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#201 in Seattle, WA

#685 in Washington

#29,866 in US

#56,047 in the World

Seattle, WA, United States of America

Cardeas Pharma Corporation

Forward Citations = 86

1 inventor:

Alan Bruce Montgomery (10 out of 27 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cardeas Pharma Corporation. Retrieved from https://idiyas.com/company/cardeas-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]